# Olive Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/olive-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Jerusalem, Israel
- Website: www.olive.earth
- Total disclosed funding: $7.3M
- Latest round: Seed (Aug 30, 2022)
- Investors on record: 6

## About

Founded in 2019 by Guy Goldman (CEO), and Corey Katz, and based in Jerusalem, Israel, Olive Diagnostics Ltd. is a health tech startup that uses artificial intelligence (AI) and derives important health data by analyzing the urine of people. In August 2022, Olive Diagnostics Ltd. raised USD 7.3 million in Seed funding from Amgen Ventures, eHealth Ventures, Geberit International AG, Mayo Clinic Medical Center, Mekorot Water, and WellFleet Capital Partners, Inc.

The firm has developed a medical device that works as a passive sensor called Olive KG mounted in toilets that measures the composition of proteins, red blood cells, nitrites, acidity, and specific weight and volume from a person’s urine, while in motion to detect or predict conditions such as kidney stones, urinary tract infections, hydration, pregnancy, ketone, glucose, specific gravity, cardiac failures, and other health diseases in real-time.

## Funding rounds

- Seed, Aug 30, 2022, $7.3M — Amgen Ventures, Mayo Clinic, Geberit International AG, Mekorot Water, eHealth Ventures, WellFleet Capital Partners, Inc.

## Investors

- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Seed
- Mayo Clinic — Seed
- Geberit International AG — Seed
- Mekorot Water — Seed
- eHealth Ventures (https://capitalatlas.ai/funds/ehealth-ventures) — Seed
- WellFleet Capital Partners, Inc. — Seed